» Articles » PMID: 34557098

MLIF Modulates Microglia Polarization in Ischemic Stroke by Targeting EEF1A1

Overview
Journal Front Pharmacol
Date 2021 Sep 24
PMID 34557098
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Monocyte locomotion inhibitory factor (MLIF) is a heat-stable pentapeptide from . Our previous study found that MLIF protects against ischemic stroke in rats and mice and exerts a neuroprotection effect in human neuroblastoma SH-SY5Y cells. Microglia/macrophage polarization has been proven to be vital in the pathology of ischemic stroke. Nevertheless, whether MLIF is able to modulate microglia/macrophage polarization remains unclear. We performed middle cerebral artery occlusion (MCAO) on C57BL/6J male mice and induced cultured BV2 microglia by oxygen-glucose deprivation (OGD), respectively. Immunfluorescence was utilized to detect the M1/2 markers, such as CD206 and CD16/32. qPCR and ELISA were used to detect the signature gene change of M1/2. The MAPK and NF-κB pathway associated proteins were measured by Western blot. To identify the protein target of MLIF, a pull-down assay was performed. We found that MLIF promoted microglia transferring from a "sick" M1 phenotype to a "healthy" M2 phenotype or . Furthermore, we proved that eukaryotic elongation factor 1A1 (eEF1A1) was involved in the modulation of microglia/macrophage polarization. Knocking down eEF1A1 by siRNA exhibited the M1 promotion effect and M2 inhibition effect. Taken together, our results demonstrated MLIF modulated microglia/macrophage polarization by targeting eEF1A1 in ischemic stroke.

Citing Articles

Mechanism of KDM4A in Regulating Microglial Polarization in Ischemic Stroke.

Du J, Liang X, Wang D, Wang Z, Shen R Appl Biochem Biotechnol. 2025; .

PMID: 40080374 DOI: 10.1007/s12010-025-05207-2.


Examining the Impact of Microglia on Ischemic Stroke With an Emphasis on the Metabolism of Immune Cells.

Lv J, Jiao Y, Zhao X, Kong X, Chen Y, Li L CNS Neurosci Ther. 2025; 31(2):e70229.

PMID: 39945118 PMC: 11822359. DOI: 10.1111/cns.70229.


Anti-CD49d Ab treatment ameliorates age-associated inflammatory response and mitigates CD8 T-cell cytotoxicity after traumatic brain injury.

Chen Z, Ford K, Islam M, Wan H, Han H, Ramakrishnan A J Neuroinflammation. 2024; 21(1):267.

PMID: 39427160 PMC: 11491007. DOI: 10.1186/s12974-024-03257-7.


Exploiting Translation Machinery for Cancer Therapy: Translation Factors as Promising Targets.

Sehrawat U Int J Mol Sci. 2024; 25(19).

PMID: 39409166 PMC: 11477148. DOI: 10.3390/ijms251910835.


eEF1A1 regulates the expression and alternative splicing of genes associated with Parkinson's disease in U251 cells.

Lei J, Aimaier G, Aisha Z, Zhang Y, Ma J Genes Genomics. 2024; 46(7):817-829.

PMID: 38776049 DOI: 10.1007/s13258-024-01516-8.


References
1.
Liu S, Hausmann S, Carlson S, Fuentes M, Francis J, Pillai R . METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis. Cell. 2019; 176(3):491-504.e21. PMC: 6499081. DOI: 10.1016/j.cell.2018.11.038. View

2.
Akintade D, Chaudhuri B . Identification of proteins involved in transcription/translation (eEF 1A1) as an inhibitor of Bax induced apoptosis. Mol Biol Rep. 2020; 47(9):6785-6792. PMC: 7561549. DOI: 10.1007/s11033-020-05736-5. View

3.
Abbas W, Kumar A, Herbein G . The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections. Front Oncol. 2015; 5:75. PMC: 4387925. DOI: 10.3389/fonc.2015.00075. View

4.
Han D, Wang J, Wen L, Sun M, Liu H, Gao Y . Remote Limb Ischemic Postconditioning Protects against Ischemic Stroke via Modulating Microglia/Macrophage Polarization in Mice. J Immunol Res. 2021; 2021:6688053. PMC: 7910075. DOI: 10.1155/2021/6688053. View

5.
Barthels D, Das H . Current advances in ischemic stroke research and therapies. Biochim Biophys Acta Mol Basis Dis. 2019; 1866(4):165260. PMC: 6981280. DOI: 10.1016/j.bbadis.2018.09.012. View